Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DRA imaging bill is back

This article was originally published in The Gray Sheet

Executive Summary

Legislation to put a stop to the imaging cuts that went into effect Jan. 1 under the Deficit Reduction Act of 2005 is introduced in the House Feb. 28. The bill, sponsored by Carolyn McCarthy, D-N.Y., Joseph Pitts, R-Pa., Gene Green, D-Texas, and 20 cosponsors, is similar to last year's "Access to Medicare Imaging Act" that garnered 142 cosponsors before the year ended. The measure calls for a two-year freeze on the cuts, which cap the technical component of imaging payments to physicians at outpatient payment levels, and a report on the cuts' potential effects on patient access from the Government Accountability Office. The new legislation, backed by the Access to Medical Imaging Coalition, also changes the statutory definition of imaging services affected by the DRA to include only magnetic resonance imaging, computed tomography, positron emission tomography and nuclear cardiology procedures. CMS indicated last year that a legislative change would be necessary to remove certain other procedures from the affected services, as stakeholders had asked (1"The Gray Sheet" Nov. 6, 2006, p. 3)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel